Followed 162 TimesTop Followed Top-Rated StocksTop-Rated Most-Upgraded StocksMost-Upgraded

NASDAQ:CRWD

CrowdStrike (CRWD) Price Target & Analyst Ratings

$167.38

+2.13 (+1.29%)

(As of 09/29/2023 ET)

Compare

Today's Range: $166.97
▼
$169.52
50-Day Range: $144.03
▼
$172.29
52-Week Range: $92.25
▼
$181.84

Volume: 2.60 million shs
Average Volume: 2.88 million shs
Market Capitalization: $39.97 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $190.26

CrowdStrike Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 41 Analyst Ratings

Consensus Analyst Price Target

$190.26
13.67% Upside

High Prediction	$240.00
Average Prediction	$190.26
Low Prediction	$130.00

Type	Current 9/30/22 to 9/30/23	1 Month Ago 8/31/22 to 8/31/23	3 Months Ago 7/2/22 to 7/2/23	1 Year Ago 9/30/21 to 9/30/22
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	36 Buy rating(s)	36 Buy rating(s)	36 Buy rating(s)	30 Buy rating(s)
Hold	5 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$190.26	$182.95	$176.88	$241.61
Predicted Upside	13.67% Upside	27.39% Upside	30.22% Upside	32.95% Upside

Get CrowdStrike Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRWD and its competitors with MarketBeat's FREE daily newsletter.

CRWD Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRWD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CrowdStrike Stock vs. The Competition

Type	CrowdStrike	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.88	2.55	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	13.67% Upside	1,082.97% Upside	698.21% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/28/2023	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$185.00	+11.47%
9/26/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$235.00	+46.95%
9/25/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$175.00 ➝ $195.00	+19.95%
9/22/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$180.00	+8.74%
9/22/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$167.00 ➝ $175.00	+7.67%
9/22/2023	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$174.00 ➝ $186.00	+14.44%
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
9/22/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$180.00 ➝ $190.00	+16.90%
9/21/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$167.00	+4.11%
9/21/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$170.00 ➝ $190.00	+16.39%
9/21/2023	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$180.00 ➝ $185.00	+11.11%
9/21/2023	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$175.00 ➝ $200.00	+20.12%
9/21/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$155.00 ➝ $170.00	+2.10%
9/21/2023	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$170.00 ➝ $200.00	+22.03%
9/21/2023	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$200.00 ➝ $215.00	+31.19%
9/21/2023	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$190.00 ➝ $200.00	+22.03%
9/21/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$180.00 ➝ $210.00	+28.13%
9/21/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$180.00 ➝ $195.00	+18.98%
9/21/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$186.00 ➝ $200.00	+22.03%
9/19/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$175.00 ➝ $200.00	+19.78%
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$200.00	+17.14%
8/31/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$175.00	+7.22%
8/31/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$200.00	+22.53%
8/31/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$188.00 ➝ $192.00	+17.51%
8/31/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$182.00 ➝ $185.00	+24.01%
8/31/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$128.00 ➝ $153.00	+2.56%
8/28/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$175.00 ➝ $200.00	+33.71%
8/23/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$162.00	+4.50%
8/23/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$170.00 ➝ $180.00	+18.16%
8/22/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$175.00 ➝ $185.00	+20.55%
6/16/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$162.00 ➝ $190.00	+18.89%
6/14/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$200.00	+30.63%
3/8/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$115.00 ➝ $130.00	+1.34%
3/8/2023	Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
3/8/2023	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$200.00 ➝ $190.00	+52.09%
12/1/2022	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$175.00	+48.75%
12/1/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
11/30/2022	MKM Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy	$200.00 ➝ $190.00	+69.48%
11/30/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$220.00 ➝ $180.00	+30.43%
11/10/2022	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
10/7/2022	Sumitomo Mitsui Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$240.00	+34.54%

9/30/2022	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$235.00	+41.82%

(Data available from 9/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

CRWD Price Target - Frequently Asked Questions

What is CrowdStrike's consensus rating and price target?: According to the issued ratings of 41 analysts in the last year, the consensus rating for CrowdStrike stock is Moderate Buy based on the current 5 hold ratings and 36 buy ratings for CRWD. The average twelve-month price prediction for CrowdStrike is $190.26 with a high price target of $240.00 and a low price target of $130.00. Learn more on CRWD's analyst rating history.
Do Wall Street analysts like CrowdStrike more than its competitors?: Analysts like CrowdStrike more than other Computer and Technology companies. The consensus rating score for CrowdStrike is 2.88 while the average consensus rating score for computer and technology companies is 2.55. Learn more on how CRWD compares to other companies.
Is CrowdStrike being downgraded by Wall Street analysts?: Over the previous 90 days, CrowdStrike's stock had 1 downgrade by analysts.

Does CrowdStrike's stock price have much upside?: According to analysts, CrowdStrike's stock has a predicted upside of 21.92% based on their 12-month price targets.
What analysts cover CrowdStrike?: CrowdStrike has been rated by Barclays, BMO Capital Markets, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, DA Davidson, Guggenheim, HSBC, Jefferies Financial Group, JMP Securities, JPMorgan Chase & Co., Macquarie, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer, Piper Sandler, Robert W. Baird, Rosenblatt Securities, Royal Bank of Canada, Scotiabank, Stephens, Stifel Nicolaus, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:CRWD) was last updated on 9/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial